Optimum Technologies (United States)

Pharmacodynamic Target Attainment for Cefepime, Meropenem, and Piperacillin-Tazobactam Using a Pharmacokinetic/Pharmacodynamic-Based Dosing Calculator in Critically Ill Patients

Emily L. Heil, David P. Nicolau, Andras Farkas et al. · Antimicrobial Agents and Chemotherapy · 2018 · 48 citations · Full text

International survey of antibiotic dosing and monitoring in adult intensive care units

Paul Williams, Alexis Tabah, Menino Osbert Cotta et al. · Critical Care · 2023 · 35 citations · Full text

Comparison of the Accuracy and Precision of Pharmacokinetic Equations To Predict Free Meropenem Concentrations in Critically Ill Patients

Gloria Wong, Andras Farkas, Rachel Sussman et al. · Antimicrobial Agents and Chemotherapy · 2014 · 31 citations · Full text

Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: the Bacteraemia-MIC project

Mercedes Delgado-Valverde, Eva Torres, Adoración Valiente-Méndez et al. · Journal of Antimicrobial Chemotherapy · 2015 · 26 citations · Full text

Comparative Evaluation of the Predictive Performances of Three Different Structural Population Pharmacokinetic Models To Predict Future Voriconazole Concentrations

Andras Farkas, Gergely Daróczi, Phillip Villasurda et al. · Antimicrobial Agents and Chemotherapy · 2016 · 25 citations · Full text

Quantitative Pharmacology, Pharmacotherapy, System Pharmacology +26